The Oncology Institute, Inc. (TOI)
| Market Cap | 305.97M |
| Revenue (ttm) | 461.04M +21.7% |
| Net Income | -54.70M |
| EPS | -0.64 |
| Shares Out | 98.38M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 824,889 |
| Open | 3.060 |
| Previous Close | 3.060 |
| Day's Range | 3.030 - 3.230 |
| 52-Week Range | 0.602 - 4.880 |
| Beta | 0.18 |
| Analysts | Strong Buy |
| Price Target | 6.00 (+92.93%) |
| Earnings Date | Nov 13, 2025 |
About TOI
The Oncology Institute, Inc., an oncology company, provides various medical oncology services in the United States. The company operates through three segments: Dispensary, Patient Services, and Clinical Trials & Other. It offers physician services, in-house infusion and dispensary, clinical trial, radiation, outpatient blood product transfusion, and patient support services, as well as educational seminars, support groups, counseling services, and 24/7 patient assistance services. The company also provides and manages clinical trials, palliati... [Read more]
Financial Performance
In 2024, The Oncology Institute's revenue was $393.41 million, an increase of 21.33% compared to the previous year's $324.24 million. Losses were -$53.01 million, -21.91% less than in 2023.
Financial StatementsAnalyst Summary
According to 3 analysts, the average rating for TOI stock is "Strong Buy." The 12-month stock price target is $6.0, which is an increase of 92.93% from the latest price.
News
U.S. Neurology Associates Partners with M33 Growth to Transform Neurological Care
DALLAS and BOSTON, Jan. 09, 2026 (GLOBE NEWSWIRE) -- M33 Growth, a Boston-based venture and growth-stage investment firm, today announced its partnership with U.S. Neurology Associates (“USNA” or the ...
The Oncology Institute Announces Leadership Promotions
Rakesh Panda appointed Chief Information Officer Nolan Mariano appointed Chief People Officer CERRITOS, Calif., Jan. 09, 2026 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI) announced t...
The Oncology Institute: Making Progress
The Oncology Institute recently achieved its first profitable Adj. EBITDA for the month and posted 37% YoY revenue growth, beating consensus by $13.9M. TOI raised FY25 guidance to $500M revenue and ex...
The Oncology Institute Announces Resignation of Board Member Gabe Ling
CERRITOS, Calif., Dec. 01, 2025 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (“TOI”) (NASDAQ: TOI), one of the largest value-based oncology groups in the United States, today announced that Gabe L...
The Oncology Institute, Inc. (TOI) Q3 2025 Earnings Call Transcript
The Oncology Institute, Inc. ( TOI) Q3 2025 Earnings Call November 13, 2025 5:00 PM EST Company Participants Mark Hueppelsheuser - General Counsel Daniel Virnich - CEO & Executive Director Rob Carter...
Ascertain and The Oncology Institute Co-Develop ‘Touchless' AI Automation for Oncology Administration
Partnership deployed touchless prior authorization system in eight weeks, achieving 95% reduction in authorization workload Partnership deployed touchless prior authorization system in eight weeks, ac...
The Oncology Institute Announces Third Quarter 2025 Earnings Release Date and Conference Call
CERRITOS, Calif., Oct. 22, 2025 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (“TOI”) (NASDAQ: TOI), a pioneer in value-based community oncology care, today announced that the company will release...
Topicus: Rising To The Topicus Of VMS Supremacy In Europe
Topicus.com Inc. (TOI:CA) is a leading European vertical market software acquirer, benefiting from a fragmented European market and low Private Equity competition. TOI's record acquisition spending in...
The Oncology Institute Launches Lung Cancer Center of Excellence in Florida Led by International Oncology Expert Dr. Edgardo Santos
CERRITOS, Calif., Sept. 02, 2025 (GLOBE NEWSWIRE) -- The Oncology Institute of Hope and Innovation (NASDAQ: TOI), a leading value-based oncology practice, today announced the launch of its Lung Cancer...
The Oncology Institute: A Promising Company In A Growing Sector
The Oncology Institute has achieved a strong growth in revenue in the previous years, justifying its stock price movement. We believe TOI will still be able to grow in the coming quarters while curren...
The Oncology Institute, Inc. (TOI) Q2 2025 Earnings Call Transcript
The Oncology Institute, Inc. (NASDAQ:TOI) Q2 2025 Earnings Conference Call August 13, 2025 5:00 PM ET Company Participants Daniel Virnich - CEO & Executive Director Mark Hueppelsheuser - Corporate Pa...
The Oncology Institute Reports Second Quarter 2025 Financial Results and Reaffirms Full Year 2025 Guidance
CERRITOS, Calif., Aug. 13, 2025 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI) (“TOI” or the “Company”), one of the largest value-based community oncology groups in the United States, ...
The Oncology Institute Announces Changes to Board of Directors
Richard Barasch to Retire; Anne McGeorge Brings Extensive Financial Experience to Role as New Chairman Richard Barasch to Retire; Anne McGeorge Brings Extensive Financial Experience to Role as New Cha...
The Oncology Institute Names Kristin England as Chief Administrative Officer
CERRITOS, Calif., July 14, 2025 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI) (“TOI”), one of the largest value-based oncology groups in the United States, announced today that Kristi...
The Oncology Institute and SilverSummit Healthplan Partner to Provide Oncology Care to Over 80,000 Medicaid Members in Nevada
CERRITOS, Calif., June 30, 2025 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI) (“TOI”), one of the largest value-based oncology groups in the United States, announced today that effect...
The Oncology Institute set to join the Russell 2000® and Russell 3000® Indexes
CERRITOS, Calif., June 03, 2025 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI) (“TOI”), one of the largest value-based oncology groups in the United States, today announced that it wil...
The Oncology Institute, Inc. (TOI) Q1 2025 Earnings Call Transcript
The Oncology Institute, Inc. (NASDAQ:TOI) Q1 2025 Earnings Conference Call May 14, 2025 5:00 PM ET Company Participants Mark Hueppelsheuser - General Counsel Daniel Virnich - Chief Executive Officer ...
The Oncology Institute Welcomes Dr. Jeff Langsam as Chief Clinical Officer
CERRITOS, Calif., May 14, 2025 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI) (“TOI”), one of the largest value-based oncology groups in the United States, announced today that Dr. Jef...
The Oncology Institute to Participate at the B. Riley Securities 25th Annual Institutional Investor Conference
CERRITOS, Calif., May 13, 2025 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI) (“TOI”), one of the largest value-based oncology groups in the United States, today announced that Dr. Dan...
The Oncology Institute Announces First Quarter 2025 Earnings Release Date and Conference Call
CERRITOS, Calif., April 23, 2025 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (“TOI”) (NASDAQ: TOI) one of the largest value-based oncology groups in the United States, today announced that the co...
TOI Launches Florida Oncology Network, a Fully Delegated Cancer Care Network, and Announces Four Additional Value-based Contracts in Q1
CERRITOS, Calif., March 31, 2025 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI) (“TOI” or the “Company”), one of the largest value-based community oncology groups in the United States,...
The Oncology Institute, Inc. (TOI) Q4 2024 Earnings Call Transcript
The Oncology Institute, Inc. (NASDAQ:TOI) Q4 2024 Earnings Conference Call March 25, 2025 5:00 PM ET Company Participants Mark Hueppelsheuser - General Counsel Daniel Virnich - CEO Rob Carter - CFO C...
The Oncology Institute Reports Fourth Quarter and Full Year 2024 Financial Results and Guidance for 2025
CERRITOS, Calif., March 24, 2025 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI) (“TOI” or the “Company”), one of the largest value-based community oncology groups in the United States,...
The Oncology Institute Announces $16.5 million Private Placement
CERRITOS, Calif., March 24, 2025 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI) (“TOI” or the “Company”), one of the largest value-based community oncology groups in the United States,...
The Oncology Institute Announces Fourth Quarter and Full Year 2024 Earnings Release Date and Conference Call
CERRITOS, Calif., March 04, 2025 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (“TOI”) (NASDAQ: TOI) one of the largest value-based oncology groups in the United States, today announced that the co...